Orbimed Advisors LLC Repare Therapeutics Inc. Transaction History
Orbimed Advisors LLC
- $4.15 Billion
- Q2 2024
A detailed history of Orbimed Advisors LLC transactions in Repare Therapeutics Inc. stock. As of the latest transaction made, Orbimed Advisors LLC holds 3,322,488 shares of RPTX stock, worth $11.1 Million. This represents 0.26% of its overall portfolio holdings.
Number of Shares
3,322,488
Previous 3,322,488
-0.0%
Holding current value
$11.1 Million
Previous $15.6 Million
29.93%
% of portfolio
0.26%
Previous 0.35%
Shares
2 transactions
Others Institutions Holding RPTX
# of Institutions
69Shares Held
36.7MCall Options Held
51.7KPut Options Held
17.7K-
Bvf Inc San Francisco, CA10.3MShares$34.6 Million1.04% of portfolio
-
Blue Owl Capital Holdings LP New York, NY3.37MShares$11.3 Million4.62% of portfolio
-
Chi Advisors LLC New York, NY2.97MShares$9.94 Million17.66% of portfolio
-
Versant Venture Management, LLC San Francisco, CA2.65MShares$8.87 Million19.39% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl2.51MShares$8.41 Million0.08% of portfolio
About Repare Therapeutics Inc.
- Ticker RPTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,937,800
- Market Cap $140M
- Description
- Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States. The company uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies that foc...